Abstract
The antitumor effector T helper 1 (Th1) and Th17 cells represent two T cell paradigms: short-lived cytolytic Th1 cells and "stem cell-like" memory Th17 cells. We report that Th9 cells represent a third paradigm-they are less-exhausted, fully cytolytic, and hyperproliferative. Only tumor-specific Th9 cells completely eradicated advanced tumors, maintained a mature effector cell signature with cytolytic activity as strong as Th1 cells, and persisted as long as Th17 cells in vivo. Th9 cells displayed a unique Pu.1-Traf6-NF-κB activation-driven hyperproliferative feature, suggesting a persistence mechanism rather than an antiapoptotic strategy. Th9 antitumor efficacy depended on interleukin-9 and upregulated expression of Eomes and Traf6. Thus, tumor-specific Th9 cells are a more effective CD4+ T cell subset for adoptive cancer therapy.
Keywords:
T cell paradigm; adoptive cell therapy; eradication of large advanced tumor; tumor-specific Th9 cells.
Copyright © 2018 Elsevier Inc. All rights reserved.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
CD4-Positive T-Lymphocytes / immunology*
-
CD4-Positive T-Lymphocytes / metabolism
-
Cell Line, Tumor
-
Gene Expression Profiling
-
Gene Expression Regulation, Neoplastic / immunology
-
Immunotherapy, Adoptive / methods
-
Interleukin-9 / genetics
-
Interleukin-9 / immunology*
-
Interleukin-9 / metabolism
-
Melanoma, Experimental / genetics
-
Melanoma, Experimental / immunology*
-
Melanoma, Experimental / therapy
-
Mice, Inbred C57BL
-
Mice, Knockout
-
NF-kappa B / genetics
-
NF-kappa B / immunology
-
NF-kappa B / metabolism
-
Proto-Oncogene Proteins / genetics
-
Proto-Oncogene Proteins / immunology
-
Proto-Oncogene Proteins / metabolism
-
T-Lymphocyte Subsets / immunology*
-
T-Lymphocyte Subsets / metabolism
-
T-Lymphocytes, Helper-Inducer / immunology*
-
T-Lymphocytes, Helper-Inducer / metabolism
-
TNF Receptor-Associated Factor 6 / genetics
-
TNF Receptor-Associated Factor 6 / immunology
-
TNF Receptor-Associated Factor 6 / metabolism
-
Trans-Activators / genetics
-
Trans-Activators / immunology
-
Trans-Activators / metabolism
Substances
-
IL9 protein, human
-
Interleukin-9
-
NF-kappa B
-
Proto-Oncogene Proteins
-
TNF Receptor-Associated Factor 6
-
Trans-Activators
-
proto-oncogene protein Spi-1